Therapeutics

151 trials 76 recruiting

Filter these 151 trials by phase, country and sponsor.

Open in Search →

Hemodynamic Phenotype-Based,Capillary Refill Time-Targeted Resuscitation In Early Septic Shock:ANDROMEDA-SHOCK-2 Ended

2024-519691-10-00 Septic Shock 6 2022-05-27
A Proof of Concept Study Non-Randomized, Single-Center Pilot Trial Assessing The Safety/Efficacy Of Dual Targeting Of Peripheral And Central… Ended

2024-518128-66-00 patients with cPRA or TGI ≥ 95% on the deceased donor k 3 2022-01-11
DAVINCY trial: optimal Duration of (fos)Aprepitant prophylaxis for nausea and Vomiting INduced by ChemotherapY in children: a double-blind p… Ended

2024-517846-32-00 Delayed chemotherapy induced nausea and vomiting (CINV) 5 2021-12-21
Adjuvant dendritic cell immunotherapy complementing conventional therapy for pediatric patients with high-grade glioma and diffuse intrinsic… Ended

2024-515295-12-00 High-grade glioma (HGG) 4 2021-10-06
Comparison of treatment with preservative-free dexamethasone 0.1% (Monofree Dexamethason) and diclofenac 0.1% (Dicloabak) eye drops versus p… Ended

2024-517572-38-00 cataract 6 2018-10-03
First-line immunotherapy using Wilms’ tumor protein 1 (WT1)-targeted dendritic cell vaccinations for malignant pleural mesothelioma Ended

2024-517970-35-00 Malignant Pleural Mesothelioma 4 2017-10-03
INTERACT MESO: Intraperitoneal Paclitaxel for Patients with Primary Malignant Peritoneal Mesothelioma – a Phase I/II Dose Escalation and Saf… Ended

2024-516738-36-00 Patients with malignant peritoneal mesothelioma 3